As earlier stated, TRD is associated with HPA axis hyperactivation, which induces an over-secretion of cortisol, which desensitizes GRs, and results in impairment of the negative feedback loop, and subsequent treatment-resistant depression symptoms. The gene discussed is BCL2A1; the disease is treatment resistant depression.